# Short-term performance of Symvess (acellular tissue engineered vessel-tyod) compared to external control data for autologous vein in treatment of extremity arterial injury

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/short-term-performance-of-symvess-acellular-tissue-engineered-vessel-tyod/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ravi R. Rajani,Fulton Velez,Tyler Knight,Laura Kauffman,Luigi Pascarella,Daniel C. Malone,Todd E. Rasmussen,Laura E. Niklason,Shamik Parikh |
| Citations | 4 |
| DOI | 10.1136/tsaco-2025-001814 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://tsaco.bmj.com/content/10/4/e001814.full.pdf |
| OpenAlex ID | https://openalex.org/W4415654766 |
| PMID | 41180255 |
| Type | article |
| Year | 2025 |

## Paper authors

- [Laura Kauffman](https://scholariq.org/researchers/laura-kauffman/)

## Paper primary topic

- [Tissue Engineering and Regenerative Medicine](https://scholariq.org/topics/tissue-engineering-and-regenerative-medicine/)

## Paper topics

- [Tissue Engineering and Regenerative Medicine](https://scholariq.org/topics/tissue-engineering-and-regenerative-medicine/)
- [Infectious Aortic and Vascular Conditions](https://scholariq.org/topics/infectious-aortic-and-vascular-conditions/)
- [Angiogenesis and VEGF in Cancer](https://scholariq.org/topics/angiogenesis-and-vegf-in-cancer/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.